Hydrophilic Intraocular Lens (IOLs) Market is Segmented By Product Type (Foldable IOLs, PMMA IOLs), By Applications (Hospitals, Clinic), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030.
[180 Pages Report] The Hydrophilic Intraocular Lens (IOLs) Market is estimated to reach at a high CAGR 5.1% during the forecast period (2023-2030). Acrylic intraocular lenses with hydrophobic or hydrophilic surfaces have a long history in clinical practice and are associated with lower PCO and rates of Nd: YAG laser capsulotomy than lenses made of other biomaterials such as silicone or hydrogel.
Hydrophilic Intraocular Lens (IOLs) Market - Strategic Insights
|
Metrics |
Details |
|
Market CAGR |
5.1% |
|
Segments Covered |
By Product Type, By Applications, and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North America |
To Get a Free Sample Click here
Market Dynamics
The rising prevalence of eye and related disorders and advancements in intraocular lens technology will drive the Hydrophilic Intraocular Lens (IOLs) Market
The rising prevalence of eye and related disorders will drive the hydrophilic intraocular lens (IOLs) market
At least 2.2 billion people worldwide have a near or distance vision impairment. In at least 1 billion or almost half of these cases, vision impairment could have been prevented or has yet to be addressed. These 1 billion people include those with severe or moderate distance vision impairment or blindness due to unaddressed corneal opacities (4.2 million), refractive error (88.4 million), glaucoma (7.7 million), cataract (94 million), diabetic retinopathy (3.9 million), and trachoma (2 million), as well as near vision. Cataract (65.2 million), age-related macular degeneration (10.4 million), glaucoma (6.9 million), corneal opacities (4.2 million), diabetic retinopathy (3 million), trachoma (2 million), and other causes (37.1 million) are other common vision impairments.
A lens implanted in the eye as part of a treatment for myopia or cataracts is called an intraocular lens (IOL). One with a natural lens in the eye is known as phakic, and one with an artificial lens in the eye is known as a pseudophakic or false lens. Hydrophilic IOLs tend to be easy for the surgeon to implant and are particularly used in the case of very small incisions. It is a more suitable surgical option than hydrophobic IOLs.
Advancements in intraocular lens technology will drive the hydrophilic intraocular lens (IOLs) market
Advanced IOL technology has made available various state-of-the-art IOLs. These new lens designs include Blue-light blocking IOLs that filter out harmful ultraviolet radiation as well as blue light, Aberration-free IOLs, which greatly improves image quality by enhancing contrast, eliminating glare and haloes, and enhancing night vision, and the newer Multifocal IOLs, which provides good unaided distance and near vision with less dependence on glasses. For high cylindrical spectacle numbers correction, Toric IOLs are also available. Depending on the patients' personal visual needs, the surgeon decides the most appropriate lens to implant in the eye.
UltraChoice 1.0 Rollable ThinLens (ThinOptX, Abingdon, Virginia) IOL is one of the recently developed lenses that will be inserted through a sub-2-mm incision (1.45-mm). It is manufactured from hydrophilic acrylic material with 18% water content. The refractive index of the material is 1.47.
On May 17, 2021, RayOne Spheric, a fully preloaded monofocal IOL, has received FDA approval.
The risk of infection will hamper the hydrophilic intraocular lens (IOLs) market
Postoperative endophthalmitis remains a serious sight-threatening complication of cataract surgery. Even though improved antiseptic and antimicrobial prophylaxis, the incidence of endophthalmitis following cataract surgery is quoted as 0.08%–0.12%. In many cases, the involved organisms are thought to originate from periocular flora. The organisms may gain entry to the eye utilizing surgical instruments, the irrigation fluid, or by contamination of the intraocular lens implant itself. Adherence of bacteria to IOLs may result from electrostatic charges and is enhanced by the formation of polysaccharide biofilms. According to the lens material, the propensity of bacteria to adhere to IOLs may vary. A report has suggested an association between using an intraocular lens with haptics made of polypropylene and an increased risk of postoperative endophthalmitis. The study compared the incidence of postoperative endophthalmitis in eyes with silicone-polypropylene (SPP) and single-piece polymethylmethacrylate (PMMA) intraocular lens implants (IOLs).
Although the number of microorganisms causing the development of chronic endophthalmitis following phacoemulsification surgery with an intraocular lens (IOL)-bag implantation has increased in recent years, most of these infections are due to anaerobic bacteria of low virulence such as Propionibacterium acnes (P. acnes) and coagulase-negative Staphylococcus. Filamentous fungi such as Aspergillus or yeasts such as Candida albicans may rarely produce these infections.
COVID-19 Impact Analysis
Hospitals and medical practices have been affected during the COVID 19 pandemic due to several protocols. The ophthalmology procedures involved in this pandemic have been affected. Surgery with an intraocular lens (IOL) comes under elective therapy as it does not treat any life-threatening disease. As people are scared to undergo surgery with an intraocular lens (IOL) due to the risk of COVID-19, there has been an impact on the Hydrophilic Intraocular Lens (IOLs) Market
Foldable IOLs segment will drive the hydrophilic intraocular lens (IOLs) market
Modern foldable IOLs generally are manufactured, marketed by having posterior square optic edges for the prevention of PCO. However, all square edges are not the same in the market. For example, glistenings have a stronger association with hydrophobic acrylic materials, which exhibit different tendencies to glistening formation than other materials. Each foldable acrylic lens design is manufactured from a different copolymer acrylic with a different refractive index, glass transition temperature (above this temperature, the polymer exhibits flexible properties and below it remains rigid), water content, mechanical properties, and other attributes.
Alcon, the eye care global leader announced AcrySof® IQ Vivity®, a first-of-its-kind intraocular lens (IOL) that is now commercially available. The non-diffractive AcrySof™ IQ Vivity™ Extended Vision Posterior Chamber Intraocular Lens Model DFT015 (referred to as AcrySof™ IQ Vivity™ IOL) is a blue light filtering and UV-absorbing foldable intraocular lens (IOL). Compared to a monofocal IOL, without increasing the incidence of visual disturbances this IOL provides an extended range of vision from distance to near.
The hospital segment will dominate the market
Hospitals with their large scale, strong financial capabilities, and a broad range of services will see an increase in this segment. Eyes are special, and only a well-trained eye surgeon or a specialist should perform surgery with an intraocular lens (IOL) on them for safe and accurate outcomes in the first attempt itself. Hospitals provide the best surgeons, healthcare facilities, and advanced treatment options. Hence, this segment will dominate the market.
Geographical Analysis
North America region will dominate the market
Rising awareness levels and developed healthcare infrastructure will raise the market in this region.
Every year approximately 4 million cataract procedures are performed in the U.S. The Tecnis Synergy and Tecnis Synergy Toric II IOLs are now available for patients undergoing cataract surgery in the United States and Canada.
Alcon, the eye care global leader and a division of Novartis, has achieved European CE Mark for the Clareon® IOL with the AutonoMe™ delivery system. It is the first-and-only disposable, automated, pre-loaded IOL delivery system that enables precise IOL delivery into the capsular bag in patients undergoing cataract surgery. the Softec HD IOL (Lenstec Inc., St. Petersburg, Florida) was granted the US Food and Drug Administration (FDA) approval for use in the United States. The Softec HD, a posterior chamber IOL, has been available for approximately ten years outside the United States.
Competitive Landscape
Major key players in the hydrophilic intraocular lens (IOLs) market are Physiol, Rayner Intraocular Lenses, Alcon, Oculentis, SAV IOL, Carl Zeiss Meditec, Ophtec, Hoya Corporation, Bausch + Lomb, Staar Surgical Company, Johnson and Johnson Tianjin JingMing New Tech. Devp. Co., Ltd, HANSON MEDITEC CO., LTD and Huaian Meide Medical Instrument Co., Ltd
Hydrophilic Intraocular Lens (IOLs) Market Key Companies to Watch
Rayner Intraocular Lenses
Overview: In 1949 Rayner manufactured the world's first IOL and it remained at the forefront of innovation for 70 years, focused on providing the best ophthalmic solutions and IOLs, driven by science to improve patient outcomes and safety. In the UK it is the only manufacturer of IOLs, with its Global Headquarters on the South Coast of England and its state-of-the-art manufacturing plant.
Product Portfolio: Rayner designs and manufactures intraocular lenses and proprietary injection devices for use in cataract surgery. Built on the clinically proven Rayner Primary IOL Platform, the 600C Aspheric is a hydrophilic acrylic aspheric monofocal IOL with Rayner's Amon-Apple 360° enhanced square edge.
Key Development: On March 26, 2021 – RayOne EMV, a new fully preloaded non-diffractive IOL, has received FDA approval. This IOL was developed in collaboration with world-renowned surgeon Professor Graham Barrett, president of the Australasian Society of Cataract & Refractive Surgeons.
Trending Topics
Laser Resurfacing devices Market
